Hepion Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Hepion Pharmaceuticals Inc cash flow-to-debt ratio. Hepion Pharmaceuticals Inc (HEPA) has a Cash Flow-to-Debt Ratio of -0.83x as of December 2025, meaning its operating cash flow of $-332.77K could theoretically repay -1% of its total liabilities ($402.40K) in one year. Check Hepion Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hepion Pharmaceuticals Inc (2012–2025)
Cash flow-to-debt ratio of Hepion Pharmaceuticals Inc from 2012 to 2025. Historical debt coverage capacity for Hepion Pharmaceuticals Inc across 14 annual periods. Also explore Hepion Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Hepion Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Hepion Pharmaceuticals Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Hepion Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Hepion Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -8.13x | $-3.27 Million | $402.40K | ▼ -55.2% |
| 2024 | -5.24x | $-18.22 Million | $3.48 Million | ▼ -38.6% |
| 2023 | -3.78x | $-40.89 Million | $10.81 Million | ▼ -12.4% |
| 2022 | -3.37x | $-34.96 Million | $10.39 Million | ▼ -13.8% |
| 2021 | -2.96x | $-31.22 Million | $10.56 Million | ▼ -48.7% |
| 2020 | -1.99x | $-16.17 Million | $8.12 Million | ▼ -31.4% |
| 2019 | -1.51x | $-7.57 Million | $4.99 Million | ▲ +39.8% |
| 2018 | -2.52x | $-15.65 Million | $6.21 Million | ▼ -131.6% |
| 2017 | -1.09x | $-8.21 Million | $7.55 Million | ▲ +22.6% |
| 2016 | -1.40x | $-16.56 Million | $11.79 Million | ▲ +71.9% |
| 2015 | -4.99x | $-9.67 Million | $1.94 Million | ▼ -1706.5% |
| 2014 | -0.28x | $-1.36 Million | $4.93 Million | ▲ +0.0% |
| 2013 | -0.28x | $-1.36 Million | $4.93 Million | ▼ -78656.3% |
| 2012 | 0.00x | $-79.70 | $227.21K | — |